Christine Loggins is the founder of ROME Therapeutics. ROME Therapeutics has raised $199M in total funding. Latest round: Series B.
Christine Loggins is not directly identified in the provided public sources as a founder or executive of ROME Therapeutics, so a sourced biography cannot be assembled with confidence. The available sources describe ROME Therapeutics as a Boston-area biotechnology company focused on the repeatome/dark genome and note its funding history, but they do not link Loggins to a specific role. Because no public-source match for Christine Loggins was provided, this record is limited to company-level facts only.
Full founder directory · Investor directory · Company funding database · Fundraising library